Pharmaceutical

AstraZeneca’s shares rise as it addresses China investigation

The UK-based drugmaker reported a 21% increase in annual revenues, reaching £43bn ($54.1bn) in 2024.

Feb 7, 2025 - 06:00
AstraZeneca’s shares rise as it addresses China investigation
The UK-based drugmaker reported a 21% increase in annual revenues, reaching £43bn ($54.1bn) in 2024.
Read the original article

Tags:

Previous Article

Dr Reddy’s and Shanghai Henlius sign agreement for HLX15

Next Article

Novo Nordisk plans new study for CagriSema, targets 2026 submission

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Cell and gene therapy companies must demonstrate strong value proposition for investment          

Cell and gene therapy companies must demonstrate strong...

Dec 7, 2024

Opinion: Clogged arteries: the unseen cost of road-blocking protests

Opinion: Clogged arteries: the unseen cost of road-bloc...

Jan 20, 2024

Genentech and NVIDIA enter generative AI-powered drug discovery deal

Genentech and NVIDIA enter generative AI-powered drug d...

Nov 22, 2023